Synopsis
exudative phase of acute lung injury
diffuse alveolar damage pattern of acute lung injury
acute fibrinous organizing pneumonia pattern (AFOP pattern)
squamous metaplasia
scattered multinucleate giant cells
vascular fibrin thrombi
pulmonary infarcts
vascular endothelial damage of both small- and mid-sized pulmonary vessels
Complications
invasive fungal disease
cytomegalovirus infection
References
Stadler K, Rappuoli R. SARS: Understanding the Virus and Development of Rational Therapy. Curr Mol Med. 2005 Nov;5(7):677-97. PMID: #16305493#
Hwang DM, Chamberlain DW, Poutanen SM, Low DE, Asa SL, Butany J. Pulmonary pathology of severe acute respiratory syndrome in Toronto. Mod Pathol. 2005 Jan;18(1):1-10. PMID: #15272286#
Peiris JS, Guan Y, Yuen KY. Severe acute respiratory syndrome. Nat Med. 2004 Dec;10(12 Suppl):S88-97. PMID: #15577937#
Peiris JS, Yuen KY, Osterhaus AD, Stohr K. The severe acute respiratory syndrome. N Engl J Med. 2003 Dec 18;349(25):2431-41. PMID: #14681510#
Drosten C, Preiser W, Gunther S, Schmitz H, Doerr HW. Severe acute respiratory syndrome: identification of the etiological agent. Trends Mol Med. 2003 Aug;9(8):325-7. PMID: #12928032#
Chan HL, Tsui SK, Sung JJ. Coronavirus in severe acute respiratory syndrome (SARS). Trends Mol Med. 2003 Aug;9(8):323-5. PMID: #12928031#